The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 223.00
Bid: 221.00
Ask: 222.00
Change: 1.50 (0.68%)
Spread: 1.00 (0.452%)
Open: 218.00
High: 223.00
Low: 218.00
Prev. Close: 221.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

9 Aug 2022 07:00

RNS Number : 3207V
PureTech Health PLC
09 August 2022
 

9 August 2022

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

8 August 2022

Number of ordinary shares purchased:

17,329

Highest price paid per share:

205.50p

Lowest price paid per share:

198.00p

Volume weighted average price paid per share:

202.02p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 4,333,150 ordinary shares in treasury and has 284,356,300 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 284,356,300, which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules. 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders.

This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Annual Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

 

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

08/08/2022

12:24:24

4

205.5

AQXE

00312221053TRLO1.1.1

08/08/2022

12:24:04

274

204.5

XLON

00312221018TRLO1.1.1

08/08/2022

12:24:01

3

204.5

TRQX

00312221010TRLO1.1.1

08/08/2022

12:24:01

5

204

TRQX

00312221009TRLO1.1.1

08/08/2022

12:23:36

38

204.5

BATE

00312220978TRLO1.1.1

08/08/2022

12:21:58

54

204.5

CHIX

00312220841TRLO1.1.1

08/08/2022

12:21:53

70

204.5

XLON

00312220835TRLO1.1.1

08/08/2022

12:21:53

102

204.5

XLON

00312220833TRLO1.1.1

08/08/2022

12:21:53

156

204.5

XLON

00312220834TRLO1.1.1

08/08/2022

12:21:49

4

204.5

TRQX

00312220824TRLO1.1.1

08/08/2022

12:18:43

44

203.5

BATE

00312220611TRLO1.1.1

08/08/2022

12:16:33

44

203.5

BATE

00312220448TRLO1.1.1

08/08/2022

12:14:24

41

203.5

BATE

00312220268TRLO1.1.1

08/08/2022

12:12:34

406

202.5

XLON

00312220156TRLO1.1.1

08/08/2022

12:12:34

4

202.5

TRQX

00312220155TRLO1.1.1

08/08/2022

12:12:34

28

202.5

AQXE

00312220154TRLO1.1.1

08/08/2022

12:12:12

43

203.5

BATE

00312220129TRLO1.1.1

08/08/2022

12:12:07

4

203.5

TRQX

00312220126TRLO1.1.1

08/08/2022

12:11:20

30

203

AQXE

00312220065TRLO1.1.1

08/08/2022

12:11:20

24

203

AQXE

00312220064TRLO1.1.1

08/08/2022

12:10:37

47

203.5

CHIX

00312219978TRLO1.1.1

08/08/2022

12:10:34

300

203

XLON

00312219975TRLO1.1.1

08/08/2022

12:10:33

329

203.5

XLON

00312219974TRLO1.1.1

08/08/2022

12:10:32

225

203.5

XLON

00312219971TRLO1.1.1

08/08/2022

12:10:32

242

203.5

XLON

00312219970TRLO1.1.1

08/08/2022

12:10:32

12

203.5

XLON

00312219969TRLO1.1.1

08/08/2022

12:10:05

4

201.5

TRQX

00312219936TRLO1.1.1

08/08/2022

12:10:05

42

201.5

BATE

00312219935TRLO1.1.1

08/08/2022

12:05:52

47

202.5

CHIX

00312219654TRLO1.1.1

08/08/2022

12:03:56

47

202.5

CHIX

00312219485TRLO1.1.1

08/08/2022

12:00:22

4

201.5

TRQX

00312219017TRLO1.1.1

08/08/2022

12:00:01

80

202

TRQX

00312218972TRLO1.1.1

08/08/2022

12:00:01

4

202

TRQX

00312218971TRLO1.1.1

08/08/2022

11:59:59

48

202.5

CHIX

00312218950TRLO1.1.1

08/08/2022

11:59:59

412

202.5

CHIX

00312218949TRLO1.1.1

08/08/2022

11:59:59

4

202.5

CHIX

00312218948TRLO1.1.1

08/08/2022

11:59:59

400

202.5

CHIX

00312218947TRLO1.1.1

08/08/2022

11:59:56

46

203

XLON

00312218943TRLO1.1.1

08/08/2022

11:59:56

7613

203

XLON

00312218944TRLO1.1.1

08/08/2022

11:59:56

464

203

AQXE

00312218941TRLO1.1.1

08/08/2022

11:59:56

29

203

AQXE

00312218942TRLO1.1.1

08/08/2022

11:59:56

640

203.5

BATE

00312218940TRLO1.1.1

08/08/2022

11:59:51

40

203.5

BATE

00312218930TRLO1.1.1

08/08/2022

11:59:49

333

204

XLON

00312218929TRLO1.1.1

08/08/2022

11:59:49

333

204

XLON

00312218928TRLO1.1.1

08/08/2022

11:58:54

6

203

XLON

00312218824TRLO1.1.1

08/08/2022

11:58:54

2

203

XLON

00312218823TRLO1.1.1

08/08/2022

10:42:49

8

200.5

AQXE

00312211560TRLO1.1.1

08/08/2022

10:40:18

70

200

XLON

00312211181TRLO1.1.1

08/08/2022

10:40:18

60

200

XLON

00312211179TRLO1.1.1

08/08/2022

10:40:18

12

200

XLON

00312211180TRLO1.1.1

08/08/2022

10:40:18

2

200

XLON

00312211178TRLO1.1.1

08/08/2022

10:40:18

314

200.5

XLON

00312211177TRLO1.1.1

08/08/2022

09:40:13

4

199

TRQX

00312204051TRLO1.1.1

08/08/2022

09:40:13

1

199

TRQX

00312204049TRLO1.1.1

08/08/2022

09:40:13

3

199

TRQX

00312204050TRLO1.1.1

08/08/2022

09:40:13

27

199

TRQX

00312204048TRLO1.1.1

08/08/2022

09:36:19

48

198.4

BATE

00312203624TRLO1.1.1

08/08/2022

09:35:26

13

199

CHIX

00312203510TRLO1.1.1

08/08/2022

09:35:26

2

199

CHIX

00312203509TRLO1.1.1

08/08/2022

09:35:26

32

199

CHIX

00312203508TRLO1.1.1

08/08/2022

09:35:26

4

199

CHIX

00312203507TRLO1.1.1

08/08/2022

09:34:52

31

198

AQXE

00312203436TRLO1.1.1

08/08/2022

09:31:44

325

198.6

XLON

00312203063TRLO1.1.1

08/08/2022

09:29:11

53

199

CHIX

00312202809TRLO1.1.1

08/08/2022

09:29:10

31

198

AQXE

00312202806TRLO1.1.1

08/08/2022

09:29:10

31

198

AQXE

00312202805TRLO1.1.1

08/08/2022

09:29:10

49

198.6

BATE

00312202804TRLO1.1.1

08/08/2022

09:28:32

400

198.6

XLON

00312202746TRLO1.1.1

08/08/2022

09:26:47

3

198.6

CHIX

00312202542TRLO1.1.1

08/08/2022

09:20:17

48

198.4

BATE

00312201870TRLO1.1.1

08/08/2022

09:19:40

311

198.2

XLON

00312201786TRLO1.1.1

08/08/2022

09:19:40

5

198.2

XLON

00312201785TRLO1.1.1

08/08/2022

09:19:33

36

198.4

CHIX

00312201766TRLO1.1.1

08/08/2022

09:19:33

19

198.4

CHIX

00312201765TRLO1.1.1

08/08/2022

09:13:53

173

198.2

XLON

00312201193TRLO1.1.1

08/08/2022

09:13:53

201

198.2

XLON

00312201192TRLO1.1.1

08/08/2022

09:13:49

32

198

AQXE

00312201185TRLO1.1.1

08/08/2022

09:10:59

47

198.4

BATE

00312200936TRLO1.1.1

08/08/2022

09:08:01

44

198.4

BATE

00312200621TRLO1.1.1

08/08/2022

09:07:20

1

198.4

CHIX

00312200516TRLO1.1.1

08/08/2022

09:07:19

20

198.4

CHIX

00312200515TRLO1.1.1

08/08/2022

09:07:19

30

198.4

CHIX

00312200514TRLO1.1.1

08/08/2022

09:07:01

297

198.2

XLON

00312200475TRLO1.1.1

08/08/2022

09:07:01

5

198.2

XLON

00312200474TRLO1.1.1

08/08/2022

09:03:47

365

198.2

XLON

00312200094TRLO1.1.1

08/08/2022

08:57:48

31

198

AQXE

00312199509TRLO1.1.1

08/08/2022

08:51:17

24

198.4

CHIX

00312198983TRLO1.1.1

08/08/2022

08:51:17

23

198.4

CHIX

00312198982TRLO1.1.1

08/08/2022

08:46:52

427

198

XLON

00312198568TRLO1.1.1

08/08/2022

08:46:52

79

198.2

XLON

00312198569TRLO1.1.1

08/08/2022

08:36:46

25

198

AQXE

00312197401TRLO1.1.1

08/08/2022

08:33:22

46

198

BATE

00312197022TRLO1.1.1

08/08/2022

08:31:52

8

198.4

CHIX

00312196838TRLO1.1.1

08/08/2022

08:31:51

12

198.4

CHIX

00312196829TRLO1.1.1

08/08/2022

08:31:49

26

198.4

CHIX

00312196826TRLO1.1.1

08/08/2022

08:31:01

3

198

AQXE

00312196664TRLO1.1.1

08/08/2022

08:21:16

337

198.2

XLON

00312195396TRLO1.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFIDTVITIIF
Date   Source Headline
9th May 202412:05 pmRNSPRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data
7th May 202412:05 pmRNSPRTC's Seaport Announces Board/Team Appointments
1st May 20247:00 amRNSTotal Voting Rights
25th Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSNotice of Results
16th Apr 202412:00 pmRNSPRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
11th Apr 202412:00 pmRNSFDA Grants PRTC's LYT-200 Fast Track Designation
9th Apr 20247:00 amRNSPRTC Launches Seaport w/ $100M; Leadership Changes
19th Mar 20247:00 amRNS$100M Tender Offer
18th Mar 20241:32 pmRNS$14B Acquisition of PRTC’s Karuna by BMS Completed
13th Mar 202411:00 amRNSFDA Grants PRTC's LYT-200 Orphan Drug Designation
6th Mar 20247:00 amRNSPDMR Notification RSU Vesting
27th Feb 202412:00 pmRNSPRTC to Present at Cowen and Leerink Conferences
27th Feb 20247:00 amRNSPRTC: Akili Positive Ph3 & Japan PMDA Submission
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20245:30 pmRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 202412:00 pmRNSPureTech to present at the JP Morgan Conference
3rd Jan 20247:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20231:31 pmRNSBMY Acquires PRTC Founded Entity Karuna for $14B
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSPRTC Year End Update & Outlook for 2024
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.